ArticleNpj viruses2025
Survival and transmission fitness of SARS-CoV-2 over the time-of-flight in an aerosolization chamber.
Article in Npj viruses, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
The impact of various environmental factors on SARS-CoV-2 transmission remains debated, partly due to limited physical experiments with infectious virus that closely replicate real-world conditions. Using a novel, self-contained containment level 3 chamber, we aerosolized the virus in different environmental conditions then collected droplets on nasal tissue, cell lines, or different materials to measure the transmission of infectious SARS-CoV-2. We found that SARS-CoV-2 survival was much shorter than previously reported for the potential of fomite transmission. Temperature, relative humidity and the presence of incinerated tobacco, cannabis, or vape products had no discernible impact on SARS-CoV-2 transmission through aerosolized droplets, but affected the survival of VSV, a non-respiratory enveloped virus. When compared to USA-WA1/2020 and the Omicron variant, Delta SARS-CoV-2 had the greatest survival during aerosolization. These findings suggest that respiratory enveloped viruses like SARS-CoV-2 may have and may be continuing to evolve higher transmission fitness through droplets.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.